Pine Valley Investments Ltd Liability Co Sells 704 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Pine Valley Investments Ltd Liability Co trimmed its position in iShares Biotechnology ETF (NASDAQ:IBB) by 14.2% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,252 shares of the financial services provider’s stock after selling 704 shares during the period. Pine Valley Investments Ltd Liability Co’s holdings in iShares Biotechnology ETF were worth $562,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of the company. Darwin Wealth Management LLC acquired a new stake in iShares Biotechnology ETF in the third quarter worth $29,000. Highline Wealth Partners LLC bought a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at $30,000. HHM Wealth Advisors LLC raised its stake in iShares Biotechnology ETF by 200.0% during the 4th quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock worth $30,000 after buying an additional 150 shares during the period. Newbridge Financial Services Group Inc. bought a new position in iShares Biotechnology ETF during the fourth quarter worth about $33,000. Finally, Hager Investment Management Services LLC acquired a new position in iShares Biotechnology ETF in the fourth quarter valued at about $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 0.6 %

NASDAQ IBB opened at $137.04 on Thursday. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57. The stock’s 50-day moving average is $135.73 and its 200-day moving average is $140.71.

iShares Biotechnology ETF Cuts Dividend

The business also recently announced a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were issued a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.